Back to RecallTracker
Health Canada Health products

MIFEGYMISO (mifepristone and misoprostol tablets) - Canadian Distribution and Administration Program

Issued May 18, 2017
Issue
Celopharma, in collaboration with Health Canada, is issuing this communication to healthcare professionals to clarify the different requirements and steps to follow in order to prescribe, order, stock, and/or dispense MIFEGYMISO, as outlined in the Distribution and Administration Program that is associated with MIFEGYMISO’s approval in Canada.